Where is Neogen Corporation (NEOG) Headed?

Neogen Corporation (NASDAQ:NEOG) is one of the best pet stocks to buy according to hedge funds. On January 28, Neogen Corporation (NASDAQ:NEOG) announced that it is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Manufactured by a third-party supplier, the product is distributed by the company.

Management reported that the recall was initiated because of a microbial contamination in certain lots of 10 mL/50 mg product vials, and that Neogen Corporation (NASDAQ:NEOG) received a series of reports of adverse events in horses following intra-articular injections of this product. This trend is inconsistent with its labeled, intended use, and the company’s investigation into the issue is ongoing. Neogen Corporation (NASDAQ:NEOG) further stated that it has not received reports of adverse events when used in a manner consistent with the labeled use, but out of an abundance of caution, it is also recalling the 2mL/20mg product vials and is proactively working with the FDA on this matter.

In a separate development, Neogen Corporation (NASDAQ:NEOG) reported a revenue of $224.7 million in its fiscal Q2 2026, down 2.8% year-over-year. Core growth rose 2.9% year-over-year, and the net loss reported for the quarter came up to $15.9 million, with an adjusted net income of $22.6 million.

Neogen Corporation (NASDAQ:NEOG) is involved in the manufacture, development, and marketing of food and animal safety products. The company’s operations are divided into the Food Safety and Animal Safety segments.

While we acknowledge the potential of NEOG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.